News & Investor Relations


Posted on 10 Sep 2011

Lotus Innovative Health CEO Receives Grand Challenges Explorations Grant

Lotus CEO Ming-Chung Wong was awarded a Grand Challenges Explorations Grant in the amount of US$100,000 for ground-breaking research in global health and development.

Lotus Innovative Health announces that its CEO, Mr. Ming-Chung Wong, is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.  Mr. Wong is pursuing an innovative global health and development research project entitled, "The Lotus Throne: The Self-Cleaning Solution to Sanitation".

Grand Challenges Explorations (GCE) funds scientists and researchers worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges.  Ming-Chung Wong's project is one of over 85 Grand Challenges Explorations Round 6 grants announced on April 28th, 2011 by the Bill & Melinda Gates Foundation.

"GCE winners are expanding the pipeline of ideas for serious global health and development challenges where creative thinking is most urgently needed.  These grants are meant to spur on new discoveries that could ultimately save millions of lives, " said Chris Wilson, director of Global Health Discovery at the Bill & Melinda Gates Foundation.

To receive funding, Mr. Wong and other GCE Round 6 winners demonstrated a bold idea in one of five critical global health and development topic areas: polio eradication, HIV, sanitation and family health technologies and mobile health.  Applications for Grand Challenges Explorations Round 8 opened in September 2011.

Our idea for the next generation of sanitation technology has its foundation in a concept that has occurred naturally for more than two thousand years, known as the "lotus effect".  We proposed the development of a novel self-cleaning toilet based on the lotus effect that will utilized UV-resistant, superhydrophobic silica coatings that have recently been developed.  This new self-cleaning system will not require water and will therefore minimize waste water while also increasing sanitary conditions in toilets.  Successful development of this project would be invaluable to further the development of countries in the emerging world.


Read more »

Posted on 2 Sep 2011

Dr. Wong Delivers Keynote at Knowledge Transfer Seminar

Knowledge Transfer Seminar Series: Commercialization of University Innovations in Technology-Based Projects
23 November 2010 at the Chinese University of Hong Kong

"What the market needs is important at every stage of the innovation process" was one of the key messages given by Dr. Kin-Ping Wong of the University of California, San Francisco, School of Medicine at the CUHK Knowledge Transfer (KT) Seminar Series, "Commercialization of University Innovations in Technology-Based Projects", organized by the Knowledge Transfer Unit (KTU) on 23 November 2010.  The seminar was hosted by Prof. Samuel Sai-Ming Sun, Director of the UGC-AoE Centre for Plant Molecular Biology and Agricultural Biotechnology.

Drawing from his own successful experiences in developing research output into viable products, Prof. Wong shared his insights into the work flow of technology transfer and various frameworks for technology evaluation, which are thought-provoking and inspiring.  A few key factors to success which Prof. Wong emphasized in his talk included the critical role of intellectual property protection by such means as patent filing, technology marketability and teamwork between the scientists and business professionals.

"If technology is a 'me-too' product or there is little market need, it will be difficult to commercialize such technology, even if it is based on high-quality science or from high-impact papers," said Dr. Wong.  It is essential to have a team of both technically-skilled scientists and business professionals with good management practices.  "Scientists should therefore try to get business partners involved at an early stage, if possible," said Dr. Wong.


Read more »

Posted on 29 Aug 2011

Lotus CSO Presents at InnoAsia 10

Dr. Kin-Ping Wong Discusses Angiogenesis Research at InnoAsia 10 in Hong Kong
26 November 2010 at CUHK

Dr. Kin-Ping Wong, CSO of Lotus Innovative Health, discussed Angiogenesis Research as part of the Biotechnology Forum of InnoAsia 10 held in Hong Kong. Angiogenesis, the growth of new blood vessels, is an important process in the development of neovascularized diseases such as cancer, rheumatoid arthritis, psoriasis and age-related macular degeneration. The goal of research on angiogenesis is to discover and characterize angiogenesis inhibitors from natural resources and develop them into new therapeutic agents for cancer and other diseases caused by abnormal angiogenesis.

Dr. Wong shared that his research results, obtained from screening hundreds of extracts and purified compounds from natural resources and traditional Chinese medicines commonly used, identified several new anti-angiogenesis compounds. Dr. Wong went on to explain that his research had characterized and tested a number of compounds in various animal disease models which showed them to be effective in shrinking solid tumors and substantially deferring the onset of rheumatoid arthritis. Pilot and large-scale production technologies for some of the compounds and extracts are currently being developed. Pre-clinical studies are being done and human clinical trials have been initiated.